Value of lung volume-reduction surgery in emphysema uncertain

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.414, 2003-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The costs associated with lung volume reduction surgery will be covered by the US Center for Medicare and Medicaid Services for US patients with emphysema who fulfil coverage criteria

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 428, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Novel Modalities and Agents in Bronchoscopic Lung Volume Reduction

By  

Current Drug Targets, Vol. 14, Iss. 2, 2013-02 ,pp. : 253-261

Bentham Science Publishers

Access to resources Recommend Favorite

Value of imatinib uncertain in CML

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Stenting worth it, but value of abciximab uncertain

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 443, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Stenting worth it, but value of abciximab uncertain

By  

Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite